CXCL10 is found in high concentrations in the brains of AD patients and activation of the CXCL10/CXCR3 axis has been shown to mediate the development of AD‐like pathology in mouse models (Krauthausen et al., 2015). Here, CXCR3 is linked to Alzheimer disease.